Dr. Alan H.B. Wu, PhD, DABCC, is considered to be among the top ranked opinion leaders in the fields of clinical chemistry, toxicology, cardiac biomarkers and pharmacogenomics. Dr. Wu is the Chief of Clinical Chemistry and Toxicology at San Francisco General Hospital. He also serves as a Professor of Laboratory Medicine, at the University of California, San Francisco, and medical director for the Pharmacogenomics Laboratory. He received his BS degrees in chemistry and biology from Purdue University in West Lafayette, Indiana, and his PhD degree in analytical chemistry from the University of Illinois in Champaign-Urbana, Illinois. Dr. Wu completed his postdoctoral fellowship in clinical chemistry at Hartford Hospital in Hartford, Connecticut. He is certified by the American Board of Clinical Chemistry in Clinical Chemistry and Toxicological Chemistry. His research interests include pharmacogenomics, clinical toxicology and cardiac biomarkers. Dr. Wu has over 400 publications in peer-reviewed journals and has written five paperback books consisting of short stories designed to promote the value of the clinical laboratory and pharmacogenomics to the general public.